Inhibiting Sphingosine-1-Phosphate Receptor 3 (S1PR3) Mitigates Pulmonary Fibrosis
en-GBde-DEes-ESfr-FR

Inhibiting Sphingosine-1-Phosphate Receptor 3 (S1PR3) Mitigates Pulmonary Fibrosis

28/03/2025 Compuscript Ltd

Pulmonary fibrosis (PF) involves the excessive accumulation of extracellular matrix, resulting in the loss of lung architecture and a decline of lung function, ultimately culminating in respiratory failure and death. Despite the availability of new effective drugs, the incidence and mortality of PF continue to rise, while its pathogenesis remains poorly understood. An early inflammatory event triggers the onset of an abnormal reparative process, leading to fibrosis. Controlling the M2 macrophage population represents a promising therapeutic strategy; however, identifying the mechanisms regulating their polarization is crucial.

In a recent study published in the Genes & Diseases journal, researchers at Children's Hospital of Chongqing Medical University and Children's Hospital of Shanghai Jiaotong University Medical School showed that knockdown or inhibition of sphingosine-1-phosphate receptor 3 (S1pr3), a receptor for the lipid signaling molecule sphingosine-1-phosphate, ameliorates bleomycin (BLM)-induced PF in mice marked by a decrease in M2 macrophage infiltration into the lung resulting from the attenuation of M2 macrophage polarization via repression of the PI3K/Akt-Stat3 signaling pathway.

The authors showed that i) bleomycin upregulates the expression of S1pr3 to the highest levels during the early stages of fibrosis, with a concomitant increase in the expression of the fibrotic markers collagen I and fibronectin, ii) S1pr3 expression was significantly higher in macrophages in mouse PF tissue, and iii) S1pr3 overexpression promotes M2 macrophage polarization in BLM-induced PF.

Further studies with a myeloid-specific S1pr3 knockout mouse model (the LysM-Cre+/S1pr3flox/flox mice, defined as S1pr3-CKO mice) and their littermates (the LysM-Cre−/S1pr3flox/flox mice, defined as S1pr3-C mice) as controls showed that i) the specific deletion of S1pr3 in macrophages ameliorates BLM-induced lung damage and fibrosis in mice, and ii) S1pr3 regulates the progression of PF by affecting the infiltration of M2 macrophages into the lung.

Additional experiments with bone marrow-derived macrophages (BMDMs) generated from S1pr3-C and S1pr3-CKO mice and subjected to IL-4 stimulation indicated that S1pr3 deficiency attenuates IL-4-induced macrophage M2 polarization. IL-4 stimulation significantly increases p-PI3K, p-Akt, and p-Stat3 levels in S1pr3-C BMDMs compared to S1pr3-CKO BMDMs, suggesting that S1pr3 affects macrophage M2 polarization by regulating the PI3K/Akt-Stat3 signaling pathway. Furthermore, administering the S1pr3 inhibitors CAY10444 and TY52156 in the early inflammatory phase of BLM-induced lung injury ameliorated fibrosis by reducing M2 macrophage polarization, suggesting that S1pr3-specific inhibitors represent a viable intervention against PF.

In conclusion, this study shows that S1pr3 contributes to PF by modulating macrophage M2 polarization through the PI3K/Akt-Stat3 signaling pathway. In addition, S1pr3 inhibitors were effective against PF in mice, hinting that these molecules represent a potential therapeutic strategy in humans.

Reference

Title of the original paper: Inhibition of sphingosine 1-phosphate receptor 3 ameliorates bleomycin-induced pulmonary fibrosis by suppressing macrophage M2 polarization.

Journal: Genes & Diseases
Genes & Diseases is a journal for molecular and translational medicine. The journal primarily focuses on publishing investigations on the molecular bases and experimental therapeutics of human diseases. Publication formats include full length research article, review article, short communication, correspondence, perspectives, commentary, views on news, and research watch.

DOI: https://doi.org/10.1016/j.gendis.2024.101244

Funding Information:
General Basic Research Project from the Ministry of Education Key Laboratory of Child Development and Disorders (China) (No. GBRP-202115)
The Chongqing Science and Technology Bureau Major Project (China) (No. cstc2020jcyj-msxmX0782).

# # # # # #

Genes & Diseases publishes rigorously peer-reviewed and high quality original articles and authoritative reviews that focus on the molecular bases of human diseases. Emphasis is placed on hypothesis-driven, mechanistic studies relevant to pathogenesis and/or experimental therapeutics of human diseases. The journal has worldwide authorship, and a broad scope in basic and translational biomedical research of molecular biology, molecular genetics, and cell biology, including but not limited to cell proliferation and apoptosis, signal transduction, stem cell biology, developmental biology, gene regulation and epigenetics, cancer biology, immunity and infection, neuroscience, disease-specific animal models, gene and cell-based therapies, and regenerative medicine.

Scopus CiteScore: 7.3 | Impact Factor: 6.9

# # # # # #

More information: https://www.keaipublishing.com/en/journals/genes-and-diseases/

Editorial Board: https://www.keaipublishing.com/en/journals/genes-and-diseases/editorial-board/

All issues and articles in press are available online in ScienceDirect (https://www.sciencedirect.com/journal/genes-and-diseases).

Submissions to Genes & Disease may be made using Editorial Manager (https://www.editorialmanager.com/gendis/default.aspx ).

Print ISSN: 2352-4820
eISSN: 2352-3042
CN: 50-1221/R
Contact Us: editor@genesndiseases.com

X (formerly Twitter): @GenesNDiseases (https://x.com/GenesNDiseases)
Attached files
  • (A) Representative images of S1pr3 immunofluorescence staining (upper panel, scale bar = 50 μm), HE staining (middle panel, scale bar = 100 μm), and Masson's trichrome staining (lower panel, scale bar = 25 μm) of lung tissues after BLM induction at different time points. The bar graph on the right shows quantitative S1pr3 expression and numerical fibrotic score (Ashcroft score). (B) Quantification of the hydroxyproline content of lung tissues at different time points after BLM administration. (C, D) Quantitative reverse transcription-PCR and Western blot analyses of S1pr3, fibronectin, and collagen I of lung homogenates. BLM, bleomycin; D0, normal control; D3/D7/D14, 3/7/14 days after BLM stimulation; MFI, mean fluorescence intensity; Col I, collagen I; Fib, fibronectin. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.
  • (A) Breeding strategy of LysM-Cre+/S1pr3flox/flox (S1pr3-CKO) and LysM-Cre−/S1pr3flox/flox (S1pr3-C) mice. (B) Representative images for co-immunostaining of CD115 and S1pr3 in lung sections from S1pr3-C and S1pr3-CKO mice on day 14 after BLM stimulation. Nuclei were stained with DAPI (blue); scale bar = 50 μm. (C) Representative images of HE staining (upper panel, scale bar = 100 μm) and Masson's trichrome staining (lower panel, scale bar = 25 μm) of lung tissues of S1pr3-C and S1pr3-CKO mice after BLM challenge. The bar graph shows the Ashcroft score. (D) Quantification of hydroxyproline content. (E, F) Quantitative reverse transcription-PCR and Western blot analysis of lung collagen I and fibronectin in S1pr3-C and S1pr3-CKO mice after BLM challenge. Col I, collagen I; Fib, fibronectin; DAPI, 4′,6-diamidino-2-phenylindole; ns, not significant. ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.
  • (A) Representative images for co-immunostaining of CD115 and Arg1 in lung sections of S1pr3-C and S1pr3-CKO mice after BLM challenge, Scale bar = 50 μm. (B, C) Quantitative reverse transcription-PCR and Western blot analysis of lung Arg1 in S1pr3-C and S1pr3-CKO mice. (D) Western blot results for S1pr3, iNOS, and Arg1 expression in BMDMs after IL-4 induction. (E) Quantitative reverse transcription-PCR analysis of Arg1, Mrc1, Chi3l3, Fizz 1, and iNOS expression in BMDMs after IL-4 induction. (F) Flow cytometry analysis of the percentage of M1 macrophages (CD11b+F4/80+CD11c+CD206− cells) and M2 macrophages (CD11b+F4/80+CD11c−CD206+ cells) in BMDMs following IL-4 stimulation. (G) Time-course Western blot analysis of IL-4-induced PI3K/Akt-Stat 3 signaling activity in BMDMs. BMDMs, bone marrow-derived macrophages; Arg1, arginase 1; Mrc1, mannose receptor 1; Chi3l3, chitinase 3-like 3; Fizz1, found in inflammatory zone 1; ns, not significant. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.
28/03/2025 Compuscript Ltd
Regions: Europe, Ireland, Asia, China
Keywords: Science, Life Sciences

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Testimonials

For well over a decade, in my capacity as a researcher, broadcaster, and producer, I have relied heavily on Alphagalileo.
All of my work trips have been planned around stories that I've found on this site.
The under embargo section allows us to plan ahead and the news releases enable us to find key experts.
Going through the tailored daily updates is the best way to start the day. It's such a critical service for me and many of my colleagues.
Koula Bouloukos, Senior manager, Editorial & Production Underknown
We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet

We Work Closely With...


  • BBC
  • The Times
  • National Geographic
  • University of Cambridge
  • iesResearch
Copyright 2025 by AlphaGalileo Terms Of Use Privacy Statement